196 related articles for article (PubMed ID: 1421424)
1. Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate/IGF-II receptor.
Vignon F; Rochefort H
Breast Cancer Res Treat; 1992; 22(1):47-57. PubMed ID: 1421424
[TBL] [Abstract][Full Text] [Related]
2. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
[TBL] [Abstract][Full Text] [Related]
3. The two mannose 6-phosphate binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor display different ligand binding properties.
Marron-Terada PG; Brzycki-Wessell MA; Dahms NM
J Biol Chem; 1998 Aug; 273(35):22358-66. PubMed ID: 9712856
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
De Leon DD; Terry C; Asmerom Y; Nissley P
Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
[TBL] [Abstract][Full Text] [Related]
5. High-affinity ligand binding by wild-type/mutant heteromeric complexes of the mannose 6-phosphate/insulin-like growth factor II receptor.
Hartman MA; Kreiling JL; Byrd JC; MacDonald RG
FEBS J; 2009 Apr; 276(7):1915-29. PubMed ID: 19236480
[TBL] [Abstract][Full Text] [Related]
6. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
Mathieu M; Vignon F; Capony F; Rochefort H
Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors.
Laurent-Matha V; Farnoud MR; Lucas A; Rougeot C; Garcia M; Rochefort H
J Cell Sci; 1998 Sep; 111 ( Pt 17)():2539-49. PubMed ID: 9701553
[TBL] [Abstract][Full Text] [Related]
8. Biosynthetic labeling of beta-hexosaminidase B: inhibition of the cellular uptake of lysosomal secretions containing [3H]hexosaminidase B by insulin-like growth factor-II in rat C6 glial cells.
Kessler U; Aumeier S; Funk B; Kiess W
Mol Cell Endocrinol; 1992 Dec; 90(1):147-53. PubMed ID: 1301395
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
Zavorka ME; Connelly CM; Grosely R; MacDonald RG
Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
[TBL] [Abstract][Full Text] [Related]
10. Reversal of cathepsin D routing modulation in MCF-7 breast cancer cells expressing antisense insulin-like growth factor II (IGF-II).
De León DD; Issa N; Nainani S; Asmerom Y
Horm Metab Res; 1999; 31(2-3):142-7. PubMed ID: 10226795
[TBL] [Abstract][Full Text] [Related]
11. The bovine mannose 6-phosphate/insulin-like growth factor II receptor. Localization of the insulin-like growth factor II binding site to domains 5-11.
Dahms NM; Wick DA; Brzycki-Wessell MA
J Biol Chem; 1994 Feb; 269(5):3802-9. PubMed ID: 8106425
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
Confort C; Rochefort H; Vignon F
Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
[TBL] [Abstract][Full Text] [Related]
13. Recognition of Dictyostelium discoideum lysosomal enzymes is conferred by the amino-terminal carbohydrate binding site of the insulin-like growth factor II/mannose 6-phosphate receptor.
Marron-Terada PG; Hancock MK; Haskins DJ; Dahms NM
Biochemistry; 2000 Mar; 39(9):2243-53. PubMed ID: 10694390
[TBL] [Abstract][Full Text] [Related]
14. The chick embryo fibroblast cation-independent mannose 6-phosphate receptor is functional and immunologically related to the mammalian insulin-like growth factor-II (IGF-II)/man 6-P receptor but does not bind IGF-II.
Yang YW; Robbins AR; Nissley SP; Rechler MM
Endocrinology; 1991 Feb; 128(2):1177-89. PubMed ID: 1846580
[TBL] [Abstract][Full Text] [Related]
15. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
[TBL] [Abstract][Full Text] [Related]
16. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells.
Schaffer BS; Lin MF; Byrd JC; Park JH; MacDonald RG
Endocrinology; 2003 Mar; 144(3):955-66. PubMed ID: 12586773
[TBL] [Abstract][Full Text] [Related]
17. Mannose 6-phosphate receptor (MPR 300) proteins from goat and chicken bind human IGF-II.
Koduru S; Yadavalli S; Nadimpalli SK
Biosci Rep; 2006 Apr; 26(2):101-12. PubMed ID: 16773463
[TBL] [Abstract][Full Text] [Related]
18. Human and hamster procathepsin D, although equally tagged with mannose-6-phosphate, are differentially targeted to lysosomes in transfected BHK cells.
Isidoro C; Baccino FM; Hasilik A
Cell Tissue Res; 1998 May; 292(2):303-10. PubMed ID: 9560473
[TBL] [Abstract][Full Text] [Related]
19. Does the overexpression of pro-insulin-like growth factor-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes?
Hoeflich A; Wolf E; Braulke T; Koepf G; Kessler U; Brem G; Rascher W; Blum W; Kiess W
Eur J Biochem; 1995 Aug; 232(1):172-8. PubMed ID: 7556147
[TBL] [Abstract][Full Text] [Related]
20. Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes.
MacDonald RG
Endocrinology; 1991 Jan; 128(1):413-21. PubMed ID: 1846107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
